Stryker Corporation SYK
Set alert
At close · Nov 2
After hours · Nov 2, 6:36 PM ET
- YTD
- -12.71%
- 1 year
- -13.88%
- Open
- 294.31
- Prev close
- 291.86
- Mkt cap
- 116.80B
- Vol
- 3.74M
- Avg vol
- 2.69M
- EPS
- 9.87
- P/E
- 31.09
- Div yield
- 1.21%
More statistics
- Low
- 293.00
- High
- 307.90
- Forward P/E
- 18.81
- Beta
- 0.77
- Short ratio
- 2.15
- Inst. own
- 83.41%
- Dividend
- 3.52
- Ex-div date
- Sep 29, 2026
- Earnings
- Feb 4, 2027
- 50-d avg
- 292.71
- 200-d avg
- 323.82
- 1y target
- 341.37
5D chart
Events in this range
- Oct 29, 2026Earnings: 3.52; estimate 3.55; surprise -0.85%
- Oct 30, 2026Rating: RBC Capital · Outperform → Outperform
- Oct 30, 2026Rating: TD Cowen · Hold → Hold
- Oct 30, 2026Rating: Citigroup · Buy → Buy
- Oct 30, 2026Rating: JP Morgan · Overweight → Overweight
- Nov 2, 2026Rating: Stifel · Buy → Buy
- Nov 2, 2026Rating: Truist Securities · Hold → Hold
Signals (134)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:55 PM | 9 hours ago |
| MACD: Buy Signal | Nov 2, 3:15 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 2:55 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 2:45 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 2:20 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 2:05 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 11 hours ago |
| RSI: Overbought | Nov 2, 1:10 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 12:50 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 12:30 PM | 12 hours ago |
| RSI: Overbought | Nov 2, 12:30 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 12:00 PM | 12 hours ago |
| RSI: Overbought | Nov 2, 10:50 AM | 14 hours ago |
| RSI: Overbought | Nov 2, 10:15 AM | 14 hours ago |
Newest 20 of 134.
News
-
13 hours ago benzinga.com
Truist Securities Reiterates Hold on Stryker, Lowers Price Target to $305
Truist Securities analyst Richard Newitter reiterates Stryker (NYSE:SYK) with a Hold and lowers the price target from $310 to $305.
17 hours ago defenseworld.net
Stryker Corporation $SYK Stock Bought by International Assets Investment Management LLC
International Assets Investment Management LLC raised its stake in shares of Stryker Corporation (NYSE: SYK) by 1,432.8% in the third quarter, according to the company in its most recent 13F filing…
-
3 days ago benzinga.com
JP Morgan Maintains Overweight on Stryker, Lowers Price Target to $340
JP Morgan analyst Robbie Marcus maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $350 to $340.
-
3 days ago benzinga.com
Citigroup Maintains Buy on Stryker, Lowers Price Target to $315
Citigroup analyst Joanne Wuensch maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $360 to $315.
-
3 days ago benzinga.com
TD Cowen Maintains Hold on Stryker, Lowers Price Target to $290
TD Cowen analyst Mathew Blackman maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $298 to $290.
3 days ago zacks.com
SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
Stryker shares plunge 11.8% after Q3 earnings and sales miss estimates, prompting a 2026 outlook cut amid weak joint procedures and execution challenges.
3 days ago prnewswire.com
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that…
-
3 days ago benzinga.com
RBC Capital Maintains Outperform on Stryker, Lowers Price Target to $375
RBC Capital analyst Kendall Au maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $420 to $375.
-
3 days ago benzinga.com
Barclays Maintains Overweight on Stryker, Lowers Price Target to $365
Barclays analyst Christopher Pasquale maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $375 to $365.
3 days ago zacks.com
SYK Q3 Earnings Call Highlights Softer Demand and Revised Outlook
Stryker cuts its 2026 outlook amid weaker joint replacement demand and supply disruptions, despite MedSurg strength, margin gains and robotics investments.
-
3 days ago benzinga.com
Canaccord Genuity Downgrades Stryker to Hold, Lowers Price Target to $300
Canaccord Genuity analyst Kyle Rose downgrades Stryker (NYSE:SYK) from Buy to Hold and lowers the price target from $385 to $300.
-
3 days ago benzinga.com
Citizens Maintains Market Outperform on Stryker, Lowers Price Target to $390
Citizens analyst Daniel Stauder maintains Stryker (NYSE:SYK) with a Market Outperform and lowers the price target from $400 to $390.
-
3 days ago benzinga.com
Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $320
Evercore ISI Group analyst Vijay Kumar maintains Stryker (NYSE:SYK) with a Outperform and lowers the price target from $335 to $320.
3 days ago benzinga.com
Incyte To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Friday
Analysts raised targets for Cheniere and Incyte, while cutting Stryker, Roblox, Intel and Honeywell; Bright Horizons was downgraded.
3 days ago benzinga.com
Pinterest Posts Downbeat Q3 Results, Joins Intel, Roblox, Twilio And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. futures fell as Pinterest missed Q3 estimates and cut guidance; Intel, ATEC, Reddit, Roblox and others slid sharply premarket.
3 days ago marketbeat.com
What Stryker (SYK) Said on Its Q3 Earnings Call
Stryker NYSE: SYK reported third-quarter organic sales growth of 7.7% and adjusted earnings per share of $3.52, while lowering its full-year outlook to reflect a slowdown in hip and knee procedures,…
3 days ago benzinga.com
Stryker Analysts Cut Their Forecasts Following Downbeat Q3 Earnings
Stryker Corp. (NYSE:SYK) on Thursday posted weaker-than-expected third-quarter results.
3 days ago benzinga.com
Stryker Analysts Cut Their Forecasts Following Downbeat Q3 Earnings
Stryker's Q3 revenue and EPS missed estimates; 2026 guidance was updated. Shares fell 10.4% as analysts cut price targets.
-
3 days ago benzinga.com
Needham Maintains Buy on Stryker, Lowers Price Target to $359
Needham analyst Mike Matson maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $418 to $359.
3 days ago 247wallst.com
Stryker's Guidance Cut Rattles Investors: What It Really Says About 2027
Medical device maker Stryker (NYSE:SYK | SYK Price Prediction) shares fell about 10% before the open Friday to $279.98, compared with Thursday's close of $311.75. The quarter missed expectations on…
-
3 days ago benzinga.com
BTIG Maintains Buy on Stryker, Lowers Price Target to $304
BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $316 to $304.
3 days ago benzinga.com
Why Civeo Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Civeo shares surged 19.9% after earnings beat estimates and FY2026 sales guidance rose; other premarket movers included SLGB, HUBC and ATEC.
4 days ago benzinga.com
Stryker (SYK) Stock Is Trending After Hours: Here's What's Happening
Stryker shares plunge 11.8% after hours as third-quarter revenue and adjusted earnings miss analyst expectations.
4 days ago seekingalpha.com
Stryker Corporation (SYK) Q3 2026 Earnings Call Transcript
Stryker Corporation (SYK) Q3 2026 Earnings Call Transcript
4 days ago zacks.com
Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
4 days ago zacks.com
Stryker (SYK) Q3 Earnings and Revenues Lag Estimates
Stryker (SYK) came out with quarterly earnings of $3.52 per share, missing the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.19 per share a year ago.
4 days ago benzinga.com
Stryker Q3 2026 Earnings Call Transcript
Stryker (NYSE:SYK) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.
4 days ago benzinga.com
Stryker Q3 2026 Earnings Call Transcript
Stryker (NYSE:SYK) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
4 days ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 16.1% to $0.92 during Thursday's after-market session. The company's market cap stands at $2.2 million. CareDx (NASDAQ:CDNA) stock rose 15.0% to…
4 days ago globenewswire.com
Stryker reports third quarter 2026 operating results
Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026:
5 days ago benzinga.com
Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test
Amazon headlines Thursday’s reports, with investors focused on whether accelerating AWS growth and heavy AI spending can support the next leg of its expansion. Eli Lilly, Mastercard, Merck,…
5 days ago zacks.com
SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?
SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.
6 days ago globenewswire.com
Stryker to participate in the 2026 Jefferies Global Healthcare Conference
Portage, Michigan, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026, at the Waldorf Hilton and ME…
1 week ago seekingalpha.com
It's Too Soon To Upgrade Stryker Corporation
Stryker Corporation remains a global leader in medical technologies, with strong segment breadth and robust product innovation. SYK delivered solid financial growth in H1 2026, with revenue up 6.1%…
1 week ago zacks.com
Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for…
1 week ago globenewswire.com
Stryker completes acquisition of ZuriMED to enhance its shoulder offering
Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and…
1 week ago defenseworld.net
Stryker Corporation $SYK Shares Purchased by CMH Wealth Management LLC
CMH Wealth Management LLC raised its stake in shares of Stryker Corporation (NYSE: SYK) by 9.3% in the undefined quarter, according to the company in its most recent filing with the Securities and…
1 week ago gurufocus.com
Is It Too Late to Buy Stryker Corp (SYK) After 3.2% Rally? GF Value Says Undervalued
On October 22, 2026, Stryker Corp (SYK) shares rose 3.2%, reaching a current price of $307.08. This movement comes amid a 52-week range of $267.00 to $392.55, i
1 week ago invezz.com
These 2 dividend stocks are worth owning for a lifetime
A dividend stock earns its place in a long-term portfolio by doing more than mailing shareholders a quarterly check. It needs a business that can fund those payments while investing sufficiently to…
2 weeks ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 weeks ago benzinga.com
Stryker Makes $400 Million Robotic Surgery Bet
Stryker invests $400M in CMR Surgical to expand into soft-tissue robotics and secure exclusive U.S. sales rights for the Versius system.
3 weeks ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
3 weeks ago benzinga.com
BTIG Maintains Buy on Stryker, Lowers Price Target to $316
BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $358 to $316.
-
3 weeks ago benzinga.com
Truist Securities Maintains Hold on Stryker, Lowers Price Target to $310
Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $340 to $310.
-
3 weeks ago benzinga.com
Barclays Initiates Coverage On Stryker with Overweight Rating, Announces Price Target of $375
Barclays analyst Christopher Pasquale initiates coverage on Stryker (NYSE:SYK) with a Overweight rating and announces Price Target of $375.
-
3 weeks ago benzinga.com
Stryker Appoints President, COO Spencer Stiles As CEO, Effective January 2027, Succeeding Kevin Lobo, Who Will Transition To Executive Chair
Stryker (NYSE:SYK), a global leader in medical technologies, today announced that as part of a planned succession process, Kevin Lobo will transition to the role of Executive Chair of the Board of…
-
1 month ago benzinga.com
TD Cowen Maintains Hold on Stryker, Lowers Price Target to $298
TD Cowen analyst Mathew Blackman maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $355 to $298.
-
1 month ago benzinga.com
Canaccord Genuity Maintains Buy on Stryker, Lowers Price Target to $385
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $400 to $385.
-
1 month ago benzinga.com
Citigroup Maintains Buy on Stryker, Lowers Price Target to $360
Citigroup analyst Joanne Wuensch maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $399 to $360.
-
1 month ago benzinga.com
Wells Fargo Maintains Overweight on Stryker, Lowers Price Target to $348
Wells Fargo analyst Larry Biegelsen maintains Stryker (NYSE:SYK) with a Overweight and lowers the price target from $418 to $348.